Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Colorectal Cancer (Part 1)”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Early research (Phase 1)UnknownNCT02352571
What this trial is testing

Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer

Who this might be right for
Neoplasm MetastasisGastric CancerColorectal Cancer
Green Cross Corporation 72
Early research (Phase 1)Study completedNCT01447732
What this trial is testing

Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

Who this might be right for
Solid TumourAdenocarcinoma of the ColorectalAdenocarcinoma of the Pancreas
Kyowa Kirin Co., Ltd. 71
Testing effectiveness (Phase 2)Active Not RecruitingNCT04440735
What this trial is testing

DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerColorectal Cancer
Kahr Medical 125
Testing effectiveness (Phase 2)Ended earlyNCT00959946
What this trial is testing

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Who this might be right for
Advanced Breast Cancer (Parts 1 and 2)Advanced Pancreatic Cancer (Part 1)Advanced Colorectal Cancer (Part 1)+2 more
Pfizer 32
Early research (Phase 1)Study completedNCT03616574
What this trial is testing

First-in-human Study of CA102N Monotherapy and CA102N Combined With Trifluridine/Tipiracil (LONSURF) in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsAdvanced or Metastatic Colorectal Cancer (mCRC)
Holy Stone Healthcare Co., Ltd 37
Early research (Phase 1)Ended earlyNCT04209465
What this trial is testing

BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.

Who this might be right for
Solid Tumor
Black Diamond Therapeutics, Inc. 91
Early research (Phase 1)Ended earlyNCT02014116
What this trial is testing

LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body

Who this might be right for
NeoplasmsNeoplasm MetastasisMelanoma+2 more
Eli Lilly and Company 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT04557449
What this trial is testing

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Who this might be right for
LiposarcomaProstate CancerBreast Neoplasms+1 more
Pfizer 362
Testing effectiveness (Phase 2)Looking for participantsNCT07262619
What this trial is testing

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

Who this might be right for
Advanced Solid TumorsMSI-H or dMMR Advanced Solid TumorsMSI-H/dMMR Gastric Cancer+4 more
Eikon Therapeutics 160
Early research (Phase 1)Looking for participantsNCT05355701
What this trial is testing

Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Who this might be right for
MelanomaNon-Small-Cell Lung CancerThyroid Cancer+2 more
Pfizer 267